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Rapid Discovery of De Novo 
Deleterious Mutations in Cattle 
Enhances the Value of Livestock as 
Model Species
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In humans, the clinical and molecular characterization of sporadic syndromes is often hindered by the 
small number of patients and the difficulty in developing animal models for severe dominant conditions. 
Here we show that the availability of large data sets of whole-genome sequences, high-density 
SNP chip genotypes and extensive recording of phenotype offers an unprecedented opportunity to 
quickly dissect the genetic architecture of severe dominant conditions in livestock. We report on the 
identification of seven dominant de novo mutations in CHD7, COL1A1, COL2A1, COPA, and MITF and 
exploit the structure of cattle populations to describe their clinical consequences and map modifier 
loci. Moreover, we demonstrate that the emergence of recessive genetic defects can be monitored by 
detecting de novo deleterious mutations in the genome of bulls used for artificial insemination. These 
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results demonstrate the attractiveness of cattle as a model species in the post genomic era, particularly 
to confirm the genetic aetiology of isolated clinical case reports in humans.
For centuries humans have taken advantage of their apparent similarities with animals to gain insights into their 
own anatomy, physiology, and diseases. In modern biology, research mainly focuses on a very limited number 
of species (i.e. laboratory animals) selected for their high reproductive rate, small generation interval and ease of 
manipulation1. The study of laboratory animals has dramatically improved our understanding of the molecular 
basis of a number of phenotypes, and in particular human genetic disorders, with the characterization of thou-
sands of genes/mutations in the past 30 years.
Nevertheless, the use of laboratory animals has limitations when it comes to the study of certain dominant 
conditions. For example, rodents, which are the most commonly studied mammals, have undergone a rapid 
evolution and display an unusual tolerance to haploinsufficiency of transcription factor genes2. The absence of 
genetic variability in inbred strains requires several generations of crossing with other strains to map spontaneous 
de novo mutations. Finally, the most harmful dominant mutations cannot be studied since (i) they result in the 
death of the carriers before they reach sexual maturity and (ii) the prolificacy of laboratory animals is often not 
high enough to produce enough affected individuals among the progeny of mosaic parents.
Livestock such as cattle have the potential to be relevant models for these dominant conditions. Cattle have 
higher effective prolificacy (i.e. through the use of artificial insemination (AI), bulls can have thousands or tens of 
thousands of offspring), greater genetic diversity, and greater similarity with humans in terms of physiology, body 
size and longevity. In the past, the costs per animal and lack of genomic tools limited the value of cattle as a model 
species. Recently there has been a rapid accumulation of whole genome sequences (WGS) of bulls, industry scale 
SNP chip genotyping data for routine genomic evaluations (with millions of animals genotyped), and compre-
hensive phenotyping in large well-recorded pedigrees (through industry performance recording). This provides a 
unique opportunity to speed up the identification of mutations associated with Mendelian diseases in cattle, and 
makes cattle an attractive model species3, 4.
The aim of this study was (i) to identify deleterious de novo mutations using WGS data as a primary source of 
information and (ii) to draw the attention of the scientific community to the opportunities offered by the bovine 
animal model.
Results and Discussion
Rapid discovery of de novo deleterious mutations using WGS data. We collected samples from 
affected animals and their healthy relatives for seven autosomal dominant conditions in four cattle breeds: glass-
eyed albino (GEA) and dominant red (DR) in Holstein cattle, neurocristopathy (NC) in Montbéliarde cattle, oste-
ogenesis imperfecta type 2 (OI) in Fleckvieh cattle, and bulldog calf syndrome (BD1, BD2 and BD3) in a Charolais 
X Salers cross and in two Holstein pedigrees (Fig. 1; for information on pedigrees see Supplementary Note 1).
We sequenced the genome of one animal per condition at nine to 20.7 × coverage on Illumina HiSeq instru-
ments using paired-end reads (see Methods). We called variants with SAMtools5 and filtered them to retain 
heterozygous polymorphisms that were absent from 1230 control genomes4 (Supplementary Table 1) and were 
predicted to be deleterious to protein function according to Ensembl Variant Effect Predictor annotations6. For 
each of the seven conditions studied, the large number of control genomes enabled us to decrease the number 
of candidate causal polymorphisms from millions to only one mutation (Table 1, Supplementary Table 2, and 
Supplementary Fig. 1).
Confirmation of the de novo nature and validation of the causality of the candidate muta-
tions. Several analyses were conducted to confirm the causality of the candidate mutations and the reliability 
of our approach.
For GEA, DR and NC, we took advantage of the large pedigrees of livestock populations and mapped the 
conditions to 1.6-, 4.6- and 0.7-Mb intervals, respectively, using case-control association testing with Illumina 
BovineSNP50 genotype data (see Methods, Supplementary Table 3). We mined the WGS data of one affected 
animal per condition and identified only 3, 4 and 2 small private mutations that were compatible with domi-
nant inheritance and located within the GEA, DR and NC associated intervals, respectively. In addition, we per-
formed structural variant detection in the sequence data of case and control animals with Pindel7, DELLY8, and 
the Integrative Genomics Viewer (IGV)9, and we did not detect any additional candidate mutation within these 
intervals. We then mined Illumina BovineSNP50 phased genotypes from case relatives and from the large French 
genomic selection database (231,115 Holstein cattle genotypes and 99,044 Montbéliarde cattle genotypes) to iden-
tify unaffected individuals carrying ancestral versions of the disease-associated haplotypes, i.e. without the caus-
ative mutations. Finally, we genotyped these specific control individuals and affected animals by PCR and Sanger 
sequencing for the candidate mutations. We observed that only mutation p.R211del in microphthalmia-associated 
transcription factor (MITF) for GEA, mutation p.K594AfsX29 in chromodomain-helicase-DNA-binding protein 
7 (CHD7) for NC and mutation p.R160C in coatomer protein complex, subunit alpha (COPA) for DR were absent 
from control animals carrying ancestral versions of the disease-associated haplotypes. Our results confirm the de 
novo nature of these mutations and support their causality (Supplementary Tables 4 and 5).
For OI, BD1 and BD2, analyzing DNA samples extracted from blood and semen with Sanger sequencing 
and/or pyrosequencing, we demonstrated that the three healthy sires of affected calves were both germline and 
somatic mosaic for mutations p.A1049_P1050delinsS in Collagen type I alpha 1 chain (COL1A1), and p.G600D 
and p.G996S in Collagen type II alpha 1 chain (COL2A1), respectively (Supplementary Figs 2–4).
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Figure 1. Brief overview of the dominant conditions studied. Glass-Eyed Albino (a–d) animals trace back 
to a mutant heifer born in 1994. Clinical features include white coat color (a), deafness, and “glass-eyes” (b). 
Partial phenotypic reversion consisting in heterochromia irides (c) or black spots on the ears (d) are sometimes 
observed. Dominant Red (e–h) is distinct from the traditional recessive red allele of the Melanocortin-1 
receptor (MC1Re) found in Holstein66. It emerged in 1980 with the birth of a red mutant heifer (MC1RD/D & 
DRDR/+) from parents which were homozygous for the dominant black allele (MC1RD/D & DR+/+). In adulthood 
MC1RD/D & DRDR/+ dominant red animals (e,f) display substantial variations in colour ranging from a light 
brown which is close to the MC1Re/e & DR+/+ recessive red coat (g), to a dark brown close to MC1RD/D & 
DR+/+ dominant black coat (h). Neurocristopathy (NC) was observed in half of the progeny of a mildly affected 
Montbéliarde bull. Its main symptoms include hypotonia (i), lack of balance and coordination in the days 
following birth, facial abnormalities, heart defects and growth delay. Osteogenesis imperfecta type 2 (OI), is 
characterized by brittle bones that are prone to fracture (e.g. hind limbs in j). It has been reported in 29% of 
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Finally, for BD3, we sequenced the unaffected parents of the bulldog calf and determined that among the 
putative deleterious variants absent from 1230 control genomes, only mutation COL2A1 p.G720S occurred de 
novo (Table 1, Supplementary Fig. 5).
Cattle, a reliable animal model for studying human genetic defects. Strikingly, clinical examina-
tions showed perfect genotype-phenotype correlations between affected calves and human patients with muta-
tions affecting the same domains of the same proteins (i.e. for BD1-3 and COL2A1, OI and COL1A1, GEA and 
MITF, and NC and CHD7), demonstrating that cattle may be a useful model for human genetic diseases.
For example, COL2A1 encodes the alpha-1 chain of type II collagen, a fibrillar collagen found in cartilage 
and the vitreous humor of the eye in the form of homotrimers. In humans, mutations in this gene can cause as 
many as 16 different conditions with both recessive and dominant inheritance depending on their nature and 
location (http://www.omim.org/entry/120140). These conditions include hypochondrogenesis/achondrogene-
sis type II (MIM: 200610), a dominant syndrome which shows a strong similarity with Bulldog calf syndrome 
(Fig. 2, Supplementary Figs 6 and 7). Interestingly, hypochondrogenesis/achondrogenesis type II is caused by 
non-synonymous polymorphisms that (i) disrupt the Gly-x-y structural motif essential for the assembly of the 
collagen triple-helix10 and (ii) occur de novo or are inherited from mosaic parents. This is exactly the case for 
the three BD mutations presented herein and the p.G960R that we previously reported4 (Fig. 2, Supplementary 
Figs 3–5). We thus report four bovine models for human hypochondrogenesis/achondrogenesis type II. 
Furthermore, in addition to the symptoms commonly described in humans, we observed liver fibrosis at necropsy 
in some of the affected calves (Supplementary Figs 6 and 7), which supports the view that abnormal accumulation 
of type II collagen among other extracellular matrix proteins may play a role in organ fibrosis11.
The most severe form of osteogenesis imperfecta (OI), i.e. OI type II (OMIM 166210) in humans and in the 
progeny of the Fleckvieh bull “Halvar PP” is characterized by bone fragility, with many pre- or perinatal fractures, 
severe bowing of long bones, undermineralization, and high perinatal mortality due to respiratory insufficiency 
(Supplementary Note 1, Supplementary Fig. 8). In humans OI type 2 is caused by heterozygous mutations in the 
COL1A1 gene (OMIM 120150) or the COL1A2 gene (OMIM 120160). Both encode respectively, the pro-alpha1 
and pro-alpha2 chains of type I collagen, a fibrillar collagen whose triple helix comprises two alpha1 chains and 
one alpha2 chain and which is the most abundant protein in the bone matrix12. More than 90% (80/88 variants 
for COL1A1 and 44/46 for COL1A2; http://www.uniprot.org/uniprot/P02452; http://www.uniprot.org/uniprot/
P08123 accessed 2016/06/01) of the mutations causing OI type 2 affect the typical Gly-x-y structural motif of 
these proteins, as is also the case for the COL1A1 p.1049_1050delinsS mutation reported here (Supplementary 
Fig. 2).
Of note, when genotyping seven affected and 20 unaffected progeny of the mosaic sire using Sanger sequenc-
ing, we found an asymptomatic male calf that carried the mutant allele (Supplementary Figs 2 and 9). Inspection 
of the raw sequencing data indicated an underrepresentation of the mutant allele in this animal, possibly resulting 
from chimaerism. This phenomenon is not rare in bovines where the twinning rate is about 1% and where anasto-
moses between twins’ placentas are frequent. Since the male calf was born from a single gestation pregnancy, we 
hypothesized that (i) it may have received blood cells from a twin that died during gestation or that (ii) it could be 
the result of an early fusion between two embryos. Genotyping of two different blood samples of this animal using 
a bovineSNP50 genotyping array yielded evidence that the healthy calf was a chimera and provided a molecular 
explanation to its unaffected phenotype (Supplementary Fig. 9). Thus, we not only report the identification of 
the first bovine model for osteogenesis imperfecta type 2 in human, but also the exceptional case of an unaffected 
mosaic bull that sired an asymptomatic chimera. This rare discovery further illustrates the power of the tools and 
resources available in livestock.
GEA, an unparalleled animal model for human Tietz syndrome. With the example of GEA, caused 
by a dominant mutation in MITF, we can also demonstrate that the bovine model is, in certain instances, a better 
model than the mouse.
MITF is a basic helix-loop-helix leucine zipper transcription factor that acts as a master regulator of melano-
cyte development, function and survival13. In humans, mutations in MITF cause two distinct autosomal domi-
nant syndromes depending on their type and location. Non-truncating mutations affecting the binding of MITF 
to the DNA have a dominant negative effect with mutant proteins interfering with the DNA binding domain 
of wild-type proteins14. Such mutations result in an albinoid-like hypopigmentation of the skin, hair and iris 
and severe hearing loss known as Tietz syndrome (MIM: 103500). In contrast, other MITF mutations cause 
Waardenburg syndrome type 2A (MIM: 193510) which is characterized by patchy depigmentation and uni- or 
bilateral deafness.
To our knowledge, seven non-truncating mutations of the MITF basic domain have been reported so far in 
non-human mammals (Supplementary Fig. 10). MITF mutations p.H209R (mitfMi-enu5 and mitfMi–bcc2), p.I212N 
(mitfMi-wh), p.R216K (mitfMi-Or) and p.R217del (mitfMi) in mouse, and p.N310S in horse cause a combination of 
white-spotting, coat color dilution and sometimes hearing loss in the heterozygous state but not Tietz syndrome 
sensu stricto15–19. Because of the mouse-specific tolerance to haploinsufficiency of transcription factor genes2, only 
the progeny of an unaffected Fleckvieh bull. Bulldog (BD) calf syndrome is a lethal form of chondrodysplasia 
characterized by a generalized shortening of long bones (k,l). BD has been reported in 4% of crossbred calves 
from a Charolais bull (BD1, k), in 21% of purebred calves from a Holstein sire (BD2, l), and in an isolated 
case born from Holstein parents (BD3). Pictures e–h were generously provided by the breeding company 
Origenplus.
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homozygote animals display a general depigmentation of the skin and hair which, in addition, is associated with 
other symptoms. In contrast, the two bovine mutations p.R210I18 and p.R211del result in a phenotype similar 
to Tietz syndrome in heterozygotes. Among them, only the MITF p.R211del mutation described in this study is 
orthologous to a mutation observed in humans, i.e. MITF p.R217del (Supplementary Fig. 10). The latter is the 
most frequent MITF mutation observed in patients with Tietz syndrome and often occurs de novo. Its recurrence 
might be due to the presence of a short nucleotide triplet repeat20. Interestingly, in a recent study, Léger et al.20 
reported that p.R217del does not always result in regular Tietz syndrome but rather in a large range of phenotypes 
with some patients showing café-au-lait macules. They also reported that sun-exposed freckles were observed 
more frequently in Asian populations suggesting possible interaction with modifier loci. Finally, Léger et al.20 
highlighted the impossibility in using the mouse as a model for this disease given the differences in transmission 
in mouse and human. In contrast, the existence of both regular Tietz phenotype and Tietz phenotype with hetero-
chromia irides and revertant patches (i.e. small black spots) in MITF p.R211del/+ cattle (Fig. 1; Supplementary 
Fig. 11) makes GEA a perfect model to investigate the molecular basis of the phenotypic reversion.
Histological and electron-microscopic studies revealed the presence of melanocytes in white skin sam-
ples from MITF p.R211del/+ cattle consisting of round-shaped cells sitting on the basal layer of the epi-
dermis (Fig. 3a–h). Melanin granules and melanosomes were observed in the epidermis of controls, but not 
in white skin samples from MITF p.R211del/+ animals. Finally, the absence of pigment was evidenced in 
the choroid of affected versus control animals (Fig. 3d,e). This set of evidence confirmed at the microscopic 
level the perfect similarity between the human and bovine conditions. A gene expression study showed 
that in white skin samples from MITF p.R211del/+ animals, MITF was normally expressed and that, in 
agreement with the absence of melanin synthesis, MITF target genes such as TYR, TYRP1 and DCT were 
down-regulated (Fig. 3i). Interestingly, the expression of these genes was only partially restored in revertant 
patches from the same individuals as compared with wild type controls. To gain further insights into the 
molecular mechanisms involved in this phenotypic reversion, we extracted genomic DNA and RNA from 
white and black skin biopsies from three MITF p.R211del/+ animals. Sanger sequencing of genomic DNA 
extracted from white and black skin patches did not reveal any sign of genetic reversion (i.e. of mutation 
from the mutant allele back to the wild type; Supplementary Fig. 10). In addition, a pyrosequencing test 
was used to quantify allelic expression. We found no difference in the wild type/mutant allele ratio between 
white and black skin samples from the same animals (Supplementary Fig. 10) indicating that neither genetic 
reversion nor allelic imbalance were involved in the phenotypic reversion observed. The persistence of 
revertant patches throughout life, their location in areas of the body rich in terms of melanocytes, and the 
dominant negative effect of this mutation14 suggest a stochastic aetiology in which rare melanoblasts having 
slightly higher levels of wildtype homodimers, would undergo a nearly normal differentiation. In conclu-
sion, we present an unparalleled mammalian model for human Tietz syndrome and the first investigation of 
the molecular mechanism underlying the revertant patches observed in some affected individuals.
Defect Coverage; Gaps
Het. 
variants
Priv. het. 
variants
Delet. priv. 
het. variants Candidate mutation Human syndromes (MIM #)
Glass-Eyed Albino (GEA) 11.5 x; 1.5% 3.1 × 106 4.4 × 103 3 MITF p.R211del Tietz syndrome (103500)
Dominant Red (DR) 13.4 x; 1.2% 3.4 × 106 3.2 × 103 3 COPA p.R160C —
Neurocristopathy (NC) 13.4 x; 0.9% 3.8 × 106 9.7 × 103 15 CHD7 p.K594AfsX29 CHARGE syndrome (214800)
Osteogenesis imperfecta 
type 2(OI)* 20.7 x; 1.1% 3.5 × 10
6 4.5 × 103 12 COL1A1 p.A1049_P1050delinsS Osteogenesis imperfecta type 2 (166210)
Bulldog Calf Syndrome 
(BD1) 12.9 x; 1.2% 3.8 × 10
6 28.4 × 103 29 COL2A1 p.G600D
Achondrogenesis type II 
(200610)
Bulldog calf syndrome 
(BD2)** 9.0 x; 1.6% 1.9 × 10
6 4.2 × 103 28 COL2A1 p.G996S
Bulldog calf syndrome 
(BD3)
15.1 x; 1.1% (15.8 x; 
1.2% & 16.2 x; 1.4%) 3.2 × 10
6 9.0 × 103 (200) 9 (1) COL2A1 p.G720S
Table 1. Results of the Whole Genome Sequencing and filtering approach. Het. variants: number of 
heterozygous variants; Priv. het. variants: number of private heterozygous variants; and Delet. priv. het. variants: 
number of deleterious private heterozygous variants after filtering for variants presents in 1230 control genomes 
or, between brackets, with 1230 control genomes and both parents. x: unit corresponding to the average 
number of time that one base pair of the genome is read. Gaps: percentage of the UMD3.1 bovine sequence 
assembly that is not covered by sequence reads. *: the sequenced animal was the mosaic sire. **: to identify 
mutations compatible with BD2 syndrome in Holstein cattle, we applied a less stringent quality threshold 
(quality score = 15 instead of 30) compared to the other defects due to the lower genome coverage (9.0 x) 
of the BD2 sequencing data (see Methods). Note that for the Holstein GEA, DR, BD2 and BD3 animals, the 
number of private heterozygous variants is inferior or close to the number of de novo mutations which may have 
accumulated since the creation of this breed considering that approximately 200 mutations accumulated at each 
generation over 20 generations. This illustrates how the small effective size of the worldwide Holstein population 
(Ne ~100) combined with the high number of control genomes for this breed (n = 345) enable to capture most 
of its genetic diversity. In contrast, the elevated number of private heterozygous variants for the Charolais X 
Salers crossbred calf BD1 reflects the small number of control genomes available for the Salers breed (n = 4).
www.nature.com/scientificreports/
6SCiEntifiC REpORTS | 7: 11466  | DOI:10.1038/s41598-017-11523-3
Figure 2. Bulldog calves show perfect genotype-phenotype correlations with humans affected by 
hypochondrogenesis/achondrogenesis type II. (a–h) Phenotypic characteristics of a bulldog calf (here the 
COL2A1 p.G720S/+ calf BD3) which, like humans affected by hypochondrogenesis/achondrogenesis type 
II, shows abnormal endochondral ossification resulting in a general shortening of long bones. (a) dorsal view 
and (b) ventral view. Note the extremely short limbs and short head. Radiographs: (c) of the left hind limb 
and (d) the left front limb showing multiple short dysplastic bones, (e) of the head demonstrating a ventrally 
rotated and dysplastic splanchnocranium. (f) Cleft palate (palatoschisis). (g) Longitudinal section through 
columna showing multiple areas of marked spinal cord compression due to abnormal epiphyseal development. 
(h) The centre of the proximal epiphysis of the femur shows non organized hypertrophic chondrocytes 
and large vessels. Ossification is not present. (HE 75x). Clinical features for BD1 and BD2 are presented in 
Supplementary Figs 6 and 7. (i) Domain and region information for the α1 chain of type II collagen obtained 
from the UniProt database (http://www.uniprot.org/; accession number: P02459). (j) Multispecies alignment 
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Large half-sib pedigrees allow for the mapping of modifier loci in clinically variable syn-
dromes. The availability of large half-sib pedigrees and routinely collected phenotypes in cattle offers the 
opportunity to explore aspects of clinically variable syndromes that are difficult to investigate in less pro-
lific species. An exemplary case is CHARGE syndrome in human which, like NC in Montbéliarde cattle, is 
caused by the haploinsufficiency of CHD7, an ATP-dependent chromatin remodeler essential for activation 
of core components of neural crest transcriptional circuitry21. “CHARGE” is an acronym coined by Pagon 
et al.22 referring to five cardinal clinical features of the syndrome: coloboma (of the eyes), heart disease, 
atresia choanae, retarded growth and retarded development and/or central nervous system anomalies, gen-
ital and/or urinary anomalies, and ear anomalies and/or deafness. Since then, diagnostic criteria have been 
reevaluated23–25; patients should harbor either four major symptoms (ocular coloboma, choanal atresia or 
stenosis, cranial nerve dysfunction or anomaly, and characteristic ears) or three major and at least three 
minor symptoms (including genital hypoplasia, developmental delay, cardiovascular malformations, growth 
deficiency, orofacial cleft, tracheoesophageal fistula, and distinctive facial features) to be considered as hav-
ing CHARGE syndrome. To date, more than one hundred pathological mutations (including frameshift, 
splice-site, missense, nonsense and structural variations) have been identified throughout the CHD7 gene. 
Most of them are private and occurred de novo, but a few cases with germline mosaicism and familial inher-
itance have also been reported26–31. No correlation between the type or location of these mutations and 
phenotypes has been observed even in large cohorts of patients, and different clinical manifestations have 
been reported in parent/child or sib pairs with the same mutation suggesting the possible involvement of 
modifier loci26–31.
Here the analysis of the numerous descendants (n = 1058) of the NC bull “Etsar” (MONFRAM002528725202), 
which is heterozygous for a frameshift mutation in CHD7 (p.K594AfsX29), allowed us (i) to observe each of the 
most common symptoms of CHARGE syndrome and (ii) to improve our knowledge on the variable clinical 
features which may be associated with this genetic defect (Fig. 4, Supplementary Note 2, Supplementary Figs 12 
and 13 and Supplementary Tables 6 and 7). In addition, it gave us a unique opportunity to map modifier loci 
influencing the clinical features of CHARGE syndrome. Although the usual approach is to compare mildly and 
severely affected individuals, the rapid death of the latter animals prevented the sampling of a sufficient number 
of them (n = 7). Therefore, we compared haplotype frequencies for sliding windows of 10 markers between 49 
mildly affected animals and 89 unaffected half-sibs genotyped with the Illumina BovineSNP50 Beadchip, using 
Fisher’s exact test for allelic association. Significant association (chromosome-wide empirical p-value = 0.03) was 
observed for seven consecutive windows constituting a 16-marker haplotype located on bovine chromosome 24 
(marker BTB-00883964 to marker ARS-BFGL-NGS-1731; Chr24:29,068,445-29,893,427; Fig. 4f). The associated 
segment was present in the heterozygous state in 24.5% (12/49) of the mildly affected animals, 2.2% (2/89) of the 
unaffected half-sibs, and in none of the seven severely affected animals. This ten-fold enrichment in frequency 
between the mildly affected and control animals is particularly striking considering that the first group con-
sists approximately of the 10% least affected individuals among carriers of the CHD7 frameshift mutation (see 
Methods). It suggests that this haplotype has a major positive effect on the clinical presentation of CHARGE syn-
drome. Remarkably, the corresponding region contains a single gene, CDH2, which is a target of the CHD7 tran-
scription factor according to the CHEA Transcription Factor Targets dataset32 available in the Harmonizome33 
(http://amp.pharm.mssm.edu/Harmonizome). Moreover, conventional and tissue specific inactivation of CDH2 
in mouse have revealed the critical role played by this gene in heart and neural tube formation34–36, two develop-
mental processes affected by CHD7 haploinsufficiency. Our results support the involvement of modifier loci in 
the variable expression of CHARGE syndrome, a hypothesis which has never been confirmed in humans because 
of the limited number of patients carrying the same mutation.
Rare conditions occurring in cattle provide interesting models for basic research. We can also 
demonstrate that natural mutations occurring in livestock species, such as the p.R160C substitution in COPA, can 
provide interesting models for basic research.
COPA is a subunit of the coat protein I complex (COPI), which mediates the retrograde transport of 
dilysine-tagged proteins from the cis-Golgi to the rough endoplasmic reticulum (ER)37, 38. Several mutations 
affecting other subunits of COPI have been reported to cause hypopigmentation together with severe phenotypes 
in zebrafish39 and mouse40, suggesting a possible involvement of this protein complex in pigmentation.
In an independent study, Dorshorst et al.41 identified the same candidate mutation for DR phenotype in 
Holstein cattle that we presented at the World Congress on Genetics Applied to Livestock Production held in 
Vancouver42. The approach described in our study proved definitively the de novo nature and the causality of the 
mutation. Hair pigment analysis41, expression studies, and histological analyses revealed that the COPA p.R160C 
substitution causes a downregulation of melanogenic genes and a switch towards the production of pheomelanin 
in animals which, being homozygous for a constitutively active MC1R receptor, should produce only eumelanin 
(Supplementary Figs 14 and 15).
of the COL2A1 proteins from different vertebrate species. Note the perfect conservation of the glycine residues 
of the typical Gly-x-y structural motif, the mutation of which causes hypochondrogenesis/achondrogenesis 
type II in humans and bulldog calf syndrome in bovine (i.e. p.G600D for BD2, p.G720S for BD3, p.G960R 
for the cases presented in Daetwyler et al.4, and p.G996S for BD2). Protein sequences accession numbers in 
Ensembl are ENSBTAP00000017505, ENSP00000369889, ENSGALP00000035064, ENSACAP00000006225, 
ENSXETP00000043834 and ENSDARP00000091007.
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Figure 3. Histological and gene expression analysis of skin biopsies from GEA and control animals. (a–c) 
Hematoxylin-eosin-stained sections of ear skin biopsies. (a) Black skin from a control black and white Holstein 
animal. Melanocytes are located on the basal layer of epidermis (indicated by arrowheads) and brown melanin 
granules are disseminated within keratinocytes. (b) Melanocytes are visible, but not melanin in white skin 
from a GEA animal. (c) Black skin from a GEA animal with a revertant phenotype. Melanin is present in the 
epidermis. Note the presence of both black and white hair. (d and e) Hematoxylin-eosin-safran stained sections 
of eyes from GEA and control animals. Note the complete lack of pigmentation of the choroid from the GEA 
animal (d) as compared with control (e). (f–h) Transmission Electronic Microscopy pictures of skin from wild-
type (f) and from a GEA animal (g). Melanocytes (arrowheads) are easily distinguished from the surrounding 
keratinocytes. Numerous melanosomes lie in the wild-type keratinocytes, while only a few abnormal ones are 
observed in the mutant skin. (h) Detail of a GEA keratinocyte cytoplasm containing abnormal melanosomes 
(arrowhead). (i) Relative expression quantification of melanogenic genes in the skin of wild-type and GEA 
Holstein animals. MITF-M expression is similar in black skin from control animals (n = 3) and in unpigmented 
(white) and revertant skin (black) from GEA animals (n = 3), showing that the regulation of expression of the 
melanogenic genes is not a consequence of a downregulation of MITF-M in mutant animals. Melanogenic genes 
(TYR, TYRP1, and PMEL) are not expressed in GEA white skin, with the exception of DCT which has already 
been shown to be regulated by MITF-independent mechanisms. In all black skins sampled from GEA revertant 
animals, the expression of melanogenic genes is partially restored. Scale bars represent 50 µM in (a) and (b); 
100 µM in (c–e); 5 µM in (f,g); and 1 µM in (h).
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Figure 4. A large bovine half-sib pedigree allows the mapping of modifier loci for CHARGE syndromes. (a–e) 
Presentation in CHD7 p.K594AfsX29/+ cattle of the different symptoms which gave rise to the CHARGE 
acronym in humans (C-coloboma (of the eyes), H-heart disease, A-atresia choanae, R-retarded growth and 
retarded development and/or central nervous system anomalies, G-genital and/or urinary anomalies, and 
E-ear anomalies and/or deafness). (a) iris coloboma highlighted by an arrowhead. (b) Heart showing tetralogy 
of Fallot; note the dextroposition of the aorta. (c) Renal cyst and its section. (d) Ears from an affected heifer 
showing abnormalities of the right pinna. Atresia choanae is not presented here but was demonstrated by the 
lack of revulsive reaction of certain animals after smelling alcohol. (e) Picture (at four years old) and scores (at 
9 months old) of the mutant sire “Etsar” (MONFRAM002528725202) for 14 morphological traits expressed in 
percentiles with respect to distributions observed in 467 young Montbéliarde bulls raised by the same breeding 
company with the same protocol. Other symptoms are presented in Supplementary Note 2, Supplementary 
Figs 12 and 13 and Supplementary Tables 6–7). (f) Mapping on chromosome 24 of a locus influencing the 
clinical features of CHARGE syndrome (see Methods). The red line indicates the chromosome-wide empirical 
significance threshold of 0.05 as determined by 10 000 permutations of phenotype data (see Methods). Seven 
consecutive windows of ten markers from BTB-00883964 to ARS-BFGL-NGS-1731 (Chr24:29,132,144–
29,762,125) had an empirical p-value of 0.03. Information on the gene content of the corresponding region is 
presented.
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Figure 5. Characterization of the effect of bovine p.R160C substitution in COPA. (a) Domain information 
for COPA obtained from the UniProt database (http://www.uniprot.org/; accession numbers: Q27954 and 
P53621) and localization of the natural mutations described in cattle (p.R160C) and in human (p.K230N, 
p.R233H, p.E241K, p.D243G). The coordinates are identical in human and bovine orthologs due to the strong 
conservation of the WD40 domain that interacts with dilysine motifs44. (b) Multispecies alignment of COPA 
proteins illustrating the strong conservation of the mutated residues among eukaryotes. Protein sequences 
accession numbers in Ensembl are respectively ENSBTAP0000000567, ENSP00000357048, FBpp0072694, 
ENSCINP00000018763, YDL145C, EAL73444 and Bra010674.1-P. (c) Ingenuity Pathway Analysis on genes 
that are markedly upregulated in the skin of dominant red versus dominant black Holstein cattle (fold change 
≥2; FDR < 0.05; according to the RNAseq data produced by Dorshorst et al.41; Supplementary Data 1) identifies 
the unfolded protein response and ubiquitin proteasome pathway as the two most significantly enriched 
canonical pathways (P < 0.001). (d) Functional annotation of downregulated genes in the same RNAseq 
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Little is known about the clinical consequences of COPA mutations in vertebrates. To our knowledge, only four 
mutations have been described so far in humans43 (Fig. 5a). All these mutations are located in a particular region 
of the human protein, at the end of the fifth - and at the beginning of the sixth WD40 repeat, and cause a new dom-
inant syndrome with incomplete penetrance characterized by autoimmune-mediated lung disease and arthritis43, 
44 (i.e. “COPA syndrome”). These human mutations have no visible effect on hair pigmentation (Anthony Shum, 
pers.comm.), which is in contrast with the bovine p.R160C mutation, located in the fourth WD40 repeat of COPA. 
Despite differences in clinical manifestations and localization within the WD40 repeat domain of the protein, we 
assumed that the bovine and human mutations might share common pathogenic mechanisms, possibly associated 
with abnormal retrograde Golgi-to-ER transport of dilysine-tagged proteins. To test this hypothesis we reanalyzed 
the RNA-sequencing data produced by Dorshorst et al.41 (Supplementary Data 1).
Strikingly, Ingenuity Pathway Analysis identified the unfolded protein response (UPR) and ubiquitin protea-
some pathway (UPP) as the two most significantly enriched canonical pathways (P < 0.001) among genes that 
are markedly upregulated in the skin of DR versus black Holstein cattle (fold change ≥2; FDR < 0.05; Fig. 5b and 
Supplementary Table 8). The UPR is a cellular stress response activated in reaction to an accumulation of un- or 
misfolded proteins in the ER. Notably, studies in humans have demonstrated that COPA variants impair binding 
to proteins targeted for retrograde Golgi-to-ER transport and cause a marked increase in ER stress in the lung 
epithelium and alveolar macrophages. The UPP is the principal mechanism for protein catabolism in the cytosol 
and nucleus of eukaryotic cells45. The upregulation of this pathway, in the context of upregulation of the UPR, is 
consistent with the need to degrade increased amounts of abnormal proteins that have been removed from the 
ER to preserve its homeostasis.
In addition, we annotated the function of the genes that are downregulated in the skin of DR versus black 
Holstein cattle (fold change ≤1; FDR < 0.05) using Enrichr46, 47. We observed a significant enrichment (P < 0.05) 
for four “MGI Mammalian Phenotype Level 3”: abnormal skin adnexa, abnormal skin morphology, abnormal 
hepatobiliary system, and abnormal respiratory system (Fig. 5c, Supplementary Table 9). The latter enrichment is 
particularly interesting considering that COPA mutations cause chronic pulmonary disease in humans. It is even 
more striking to note that it comprises genes whose mutation in mice cause lung malformations (e.g. CTGF48, 
NFIB49 and PDPN50) and genes involved in immune response/inflammation (e.g. IL2551, IL3352, MMP953 and 
RELB54). Such a combination of general perturbation of the immune system and subnormal development of a 
specific organ could explain the tissue-specific nature of the autoimmune manifestations observed in human 
COPA syndrome.
Three genes among those that are downregulated in skin samples from DR versus black Holstein cattle par-
ticularly caught our attention (RELB, IL25 and NFIB). RELB, is the only gene common to the four Mammalian 
Phenotypes previously mentioned. Its loss-of-function in mouse causes inflammatory cell infiltration of organs54, 
a frequent finding in patients with autoimmune disorders. Moreover, Valéro et al.55 demonstrated that defec-
tive NF-kappa B/RELB pathway was associated with inefficient expansion of thymocyte and dendritic cells in 
autoimmune-prone New Zealand black mice. IL25 is the second most downregulated gene (fold change = 0.11) 
and a key regulator of inflammatory and autoimmune diseases51. Downregulation of both RELB and IL25 genes 
could play a central role in autoimmunity in COPA syndrome patients. Finally, to the best of our knowledge, 
NFIB is the only gene among 642 differentially expressed genes (FDR < 0.05; Supplementary Data 1) to poten-
tially affect both lung development and melanogenesis. Indeed, NFIB is essential for lung maturation49 and also 
controls epithelial-melanocyte stem cell behaviour56. A downregulation of NFIB (fold change = 0.62; P < 0.0001) 
could be the primary cause of the downregulation of eight hair keratin genes (KRT17, KRT25, KRT35, KRT71, 
KRT73, KRT74, KRT79 and KRT85; 0.51≤ fold change ≤0.66) and the differential expression of five genes 
involved in melanogenesis (ATRN which is upregulated with a fold change of 1.74 and LEF1, OCA2, TFAP2A, and 
TYRP1 which are downregulated; 0,36≤ fold change ≤0,73). Interestingly, immunohistochemical analysis with 
rabbit polyclonal antibodies against NFI transcription factors (i.e. NFIA, NFIB, NFIC and NFIX) revealed marked 
differences in terms of intracellular signal distribution between skin samples from DR animals (COPA+/−) and 
dominant black and recessive red animals (COPA+/+). This result suggests that, in skin epithelial cells, COPA 
p.R160C mutation affects not only the expression of NFIB but also the cellular transport of at least one of the NFI 
transcription factors (Fig. 5e–h).
In conclusion, these results call for a thorough clinical examination of COPA+/− cattle and provide inter-
esting avenues to explore in order to better understand the pathogenetic mechanisms associated with mutations 
affecting WD40 repeats of COPA.
Detection of de novo mutations in the genome sequence of elite sires – towards in silico iden-
tification of recessive genetic defects. After identifying mutations causing dominant conditions, we 
data using Enrichr46, 47 reveals a significant enrichment (P < 0.05) for four “MGI Mammalian Phenotype 
Level 3′. Results of gene set enrichment analyses are presented in Supplementary Tables 8 and 9. Font size is 
proportional to the fold change in (c) and to the inverse of the fold change in (d). (e–h) Immunohistochemical 
analysis with rabbit polyclonal antibodies against NFI transcription factors in epidermis from dominant black 
(MC1RD/D, DR+/+), recessive red (MC1Re/e, DR+/+), and dominant red (MC1RD/D, DRDR/+) Holstein animals. 
Scale bars correspond to 50 µm. NFI proteins are revealed with HRP-Green system, and all samples have been 
counterstained with hematoxylin. Staining is absent in negative control (a; recessive red), shows a nuclear and 
cytoplasmic distribution in dominant black (f) and recessive red (g) skins, while the distribution is only nuclear 
in dominant red skin (h). This observation was confirmed in samples from different animals (n = 3, 2 and 3 for 
f–h respectively).
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Figure 6. Identification of a de novo mutation causing recessive anhidrotic ectodermal dysplasia (AED) before 
the emergence of this defect in the population. (a) One-month old control calf. (b) One-month old AED 
affected calf showing generalized hypotrichosis. (c) Hoof of the same AED calf with no notable malformations. 
Note that in humans most AED patients have normal nails too. (d) Detail of the head of a five-month-old AED 
calf, showing eyelashes and normal development of horns. (e) Muzzle of the same calf showing normal vibrissae 
and extreme skin dryness due to the absence of nasolabial glands (see also Supplementary Fig. 19). (f) X-ray of 
the skull of a one-month old calf showing a complete absence of incisors and the presence of only one upper 
molar on each side. (g,h) Detail of one upper molar showing abnormal cusps and deep grooves. (i,j) Histological 
sections of skin biopsies from control (i) and AED (j) one-month-old calves. In AED animals, the epidermis 
(ep) is acanthotic (i.e. thickened). The number of hair follicles is greatly reduced and deep portions of them are 
atrophic or absent. Sweat glands (sw) are absent. Sebaceous glands (se) appear normal but a number of them are 
“orphan” (i.e. without associated hair follicle). Scale bars represent 500 µm. (k) Yearly estimation of the number 
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investigated the feasibility of anticipating the emergence of recessive genetic defects by detecting de novo delete-
rious mutations in the genome of healthy AI bulls. To achieve that goal, we screened the genomes of 43 French 
sires (24 Holstein, 11 Montbéliarde, five Normande and three Charolais) born one to four generations before the 
current population (since recessive defects typically emerge at the fifth generation with the first consanguineous 
mating between descendants of a common ancestor).
We identified 18 private deleterious mutations, out of which seven were confirmed to be de novo muta-
tions after genotyping by PCR and Sanger sequencing of the bulls and several of their close relatives (Methods, 
Supplementary Table 10, Supplementary Fig. 16). Except for FAM189A1 and CSNK1G2 for which, to our knowl-
edge, no homozygous mutant has been described in mammals, the five other mutations in COL6A3, EDAR, 
ITGA3, SLC35A3 and SOWAHB, are expected to cause severe recessive conditions leading to embryonic lethality, 
perinatal mortality or euthanasia according to the literature (Supplementary Table 10).
As a proof of concept, we investigated the putative effect of a frameshift mutation in the Ectodysplasin A 
Receptor (EDAR p.P161RfsX97) that was found on the paternal chromosome of the Charolais bull “Invincible” 
(CHAFRAM001893105503 born in 1993).This mutation is predicted to result in a truncated receptor lacking the 
Death Domain (Supplementary Fig. 17) which is essential for the interaction with the EDAR-Associated Death 
Domain Protein (EDARADD) and the activation of downstream signaling pathways57. In humans, mutations 
in EDAR and in other members of the ectodysplasin pathway (i.e. EDA and EDARADD) are known to cause 
anhidrotic ectodermal dysplasia58 (AED, MIM: 305100, 129490, 224900, 614940 and 614941), a syndrome char-
acterized by hypotrichosis (sparseness of hair), hypo- or an-hidrosis (reduced ability to sweat), and hypodontia 
(congenital absence of teeth). Here, we took advantage of the Charolais natural mating population which has a 
shorter generation interval than AI breeding schemes and mined the pedigree databases for consanguineous 
matings between descendants of “Invincible”. We estimated that 14 out of 344,564 Charolais calves born in 2013 
were expected to be homozygous mutants. In agreement with this estimation, a survey enabled us to detect ten 
calves, born from unaffected parents, and showing symptoms of anhidrotic ectodermal dysplasia (see Methods, 
Fig. 6 and Supplementary Figs 18 and 19). Of note, affected calves grew normal horns suggesting that the ectod-
ysplasin pathway, which plays a key role in the differentiation of skin appendages in vertebrates58, is not involved 
in horn ontogenesis. Thus, these animals represent an appealing model in evolutionary and developmental biol-
ogy. Genotyping of seven affected calves using the Illumina BovineSNP50 array revealed that, at the genome 
scale, they were homozygous for a single shared haplotype of 26 Mb on chromosome 11, encompassing EDAR. 
Subsequent genotyping by PCR and Sanger sequencing confirmed that these seven animals were also homozy-
gous for the EDAR p.P161RfsX97 mutation. Furthermore, screening of the French genomic selection database 
(8179 Charolais animals) revealed the existence of three unaffected animals which were also homozygous for the 
same 26-Mb IBD segment but only heterozygous for the EDAR mutation. Pedigree analysis demonstrated that 
one of the haplotypes of these individuals could be traced back to Invincible whereas the other haplotype origi-
nated from the sire of Invincible and not directly from him. These results confirm the causality of the mutation 
and validate our approach for anticipating the emergence of new recessive disorders.
Importantly, this strategy can easily be adapted to investigate the phenotypic consequences of de novo muta-
tions affecting poorly or uncharacterized genes such as FAM189A1 and CSNK1G2 and thus improve the func-
tional annotation of mammalian genomes.
Conclusion
We have demonstrated that the availability of large databases in cattle combined with the typical structure of 
livestock populations facilitate the rapid detection and functional characterization of de novo deleterious muta-
tions. The study of mutations underlying sporadic syndromes in cattle, which also occur in humans, offers an 
interesting alternative to laboratory animals for confirming the genetic aetiology of isolated clinical case reports 
and gaining insights into the molecular mechanisms involved. In addition, the study of mutations affecting poorly 
characterized genes increases the attractiveness of cattle and other farm animals to annotate their functions and 
become models for basic research. Finally, with the increasing sequencing of young elite bulls, the detection of de 
novo deleterious mutations in their genomes will enable the management of recessive defects in livestock popula-
tions before a large number of affected calves emerge.
Methods
Ethics statement. Blood and ear biopsies were collected by veterinarians or by agricultural technicians 
licensed by the French Departmental Breeding Establishments (Etablissements Départementaux de l’Elevage 
(EDE)) during routine ear tagging, sampling for annual prophylaxis, paternity testing and genotyping for genetic 
defects or genomic selection. Semen was provided by breeding organizations. All invasive procedures were per-
formed post-mortem either on animals that had died of natural causes, or after euthanasia or slaughter for meat 
production, thus no ethical evaluation was required. All animals used in this study were kept according to Swiss 
or European laws for bovine production, and experiments reported in this work comply with the ethical guide-
lines of the French National Institute for Agricultural Research (INRA) and its research partners participating 
of calves predicted to be born homozygous for the g.44462236_44462237insC mutation on chromosome 11 
which is predicted to cause a frameshift and premature truncation of EDAR. The total numbers of calves with 
both parents related to primo-mutant bull Invincible, as well as their coefficient of inbreeding (COI) are also 
presented. (l) Electrophoregrams of a homozygous (Ins/Ins) AED affected calf, a homozygous wild-type (Wt/
Wt) animal and a heterozygous carrier of the mutation (Wt/Ins).
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in the present study. All the samples and data analyzed were obtained with the permission of breeders, breeding 
organizations and contributing research groups.
Animals, sampling and phenotyping (all the studies). Details on animals, phenotypes and sample col-
lection for each condition and each analysis are presented in Supplementary Note 1 and Supplementary Table 1.
DNA extraction (all the studies). Genomic DNA was extracted from blood, tissues or sperm using stand-
ard extraction protocols. For quantifying allelic dosage in white and black skin samples from revertant GEA 
animals using pyrosequencing, genomic DNA was extracted from cryocuts from ear biopsies (without hair or 
cartilage) with the Nucleospin tissue genomic DNA kit (Macherey-Nagel).
Whole Genome Sequencing, read mapping, variant calling and filtering for heterozygous pri-
vate deleterious mutations (all the studies). Paired-end libraries with a 250-bp (for BD1, DR, GEA 
and NC) or a 400-bp (for BD2, OI, and the BD3 trio) insert size were generated using the TruSeq DNA Sample 
Prep Kit (Illumina; for DR and GEA) or the NEXTflex PCR-Free DNA Sequencing Kit (Biooscientific; for BD1, 
BD2, NC, OI, and the BD3 trio). Libraries were sequenced on one lane of Illumina HiSeq. 2000, 2500 or 3000 
instruments each using 2 × 101 bp (for BD1, DR, GEA and NC) or 2 × 150 bp paired-end reads (for BD2, OI, and 
the BD3 trio). Reads were mapped on the UMD3.1 bovine sequence assembly using BWA-MEM59. Reads with 
multiple alignments were removed. PCR duplicates were filtered and variants were called using SAMtools rmdup 
and pileup options5. Only variants with a quality score (QUAL) of > = 30 and a mapping quality (MQ) score of 
> = 30 were considered with the exception of BD2 for which a less stringent quality threshold (QUAL > = 15) 
was applied due to the lower genome coverage (9 x) as compared with the other defects. For each genetic defect 
we assumed the causative mutation is dominant and occurred de novo. We therefore retained only heterozygous 
polymorphisms that were absent from analogous whole genome sequencing data from 1230 control animals 
(Supplementary Table 1). Analysis of pedigree information, demonstrated that none of the 1230 control animals 
were descended from any of the first mutant animals for the different conditions studied. Within the genome of 
each affected animal, heterozygous private variants supported by only one read on each strand were removed to 
avoid possible artefacts created by reading twice an error present on a fragment displaying an insert size that was 
too small. SNP and Indels were then annotated using Ensembl VEP6. Only private frameshift mutations, in-frame 
insertions or deletions, stop gain or loss variants, polymorphisms affecting splice donor or splice acceptor sites, 
and deleterious missense polymorphisms were retained. The reliability of the annotation was verified on the 
UCSC genome browser (http://genome.ucsc.edu/; accessed 2016/05/10) using the “RefSeq Genes”, “Non-cow 
RefSeq genes”, “Cow mRNAs from GenBank” and “Cow ESTs that have been spliced” tracks. Polymorphisms pre-
dicted to affect a transcript that was not supported by the alignment of bovine mRNAs or orthologous genes were 
considered as non-coding variants. Finally, to predict the phenotypic consequences of the remaining variants, we 
made a search for the corresponding genes in the Online Mendelian Inheritance in Man (OMIM; www.omim.org) 
and Mouse Genome Informatics (MGI; www.informatics.jax.org) databases.
The same approach was used to detect heterozygous private deleterious mutations in the genomes of healthy 
AI sires to anticipate the emergence of novel recessive disorders. For this pilot study we selected 43 bulls used 
in France (to benefit from the network of the French National Observatory of bovine Anomalies for subsequent 
verifications; http://www.onab.fr/) and born one to four generations before the animals currently in use (since 
consanguineous mating between descendants of a common ancestor are more likely to occur after the fifth gen-
eration). These 43 animals consisted of 24 Holstein, 11 Montbéliarde and five Normande bulls born in 1996 or 
after, and three Charolais bulls born in 1993 or after. Two generations of 6.5 or 7 years and two subsequent gen-
erations of 2.5 or 3.5 years were considered for dairy and beef breeds, respectively, to account for the reduction of 
generation interval recently allowed by genomic selection. In a first step, we selected the heterozygous deleterious 
variants that were found only in one of the 43 genomes and not in the other control genomes (Supplementary 
Table 1). These private deleterious variants consists either (i) in recent mutations that occurred on haplotypes 
that are also observed in their original form (i.e. without these mutations) in other genomes in the dataset or 
(ii) in rare (and predominantly ancient) polymorphisms located on haplotypes carried by a single animal in the 
dataset. To discriminate these two groups of variants, and to reduce as much as possible the proportion of false 
positive results in our screening for deleterious de novo mutations, we calculated the number of private mutations 
in a +/− 2.5 Mb interval around each private deleterious mutation in the genome of each carrier animal. We con-
sidered arbitrarily that private deleterious variants observed in animals having 10 private mutations or less in the 
investigated intervals were likely recent mutations that occurred on non-rare haplotypes. Therefore, we retained 
only these mutations for further studies.
Because the lack of large databases for structural variations precluded their efficient filtering, we did not sys-
tematically investigate these polymorphisms (which are expected to represent only 1% of the total genomic varia-
tion). However, we used Pindel7, DELLY8 and IGV9 to identify structural variants in the BD3 trio and in the GEA, 
DR and NC mapping intervals (see below).
Mapping of the DR, GEA and NC defects. Animals were specifically sampled according to their phe-
notype or origin, or were extracted from the large French national data base of genotypes for genomic selection. 
Animals were genotyped with the Illumina BovineSNP50 or EuroG10K Beadchips (Details in Supplementary 
Table 1). The EuroG10K Beadchip is a custom version of the BovineLD v2.0 BeadChip (https://support.illumina.
com/downloads/bovineld-v2-0-product-files.html) comprising the same core marker set of 7931 SNP and fluc-
tuating sets of additional markers. All of these genotypes were included in the genomic selection procedure60 and 
were phased and imputed with the FImpute software61 considering large bovine reference populations (231,115 
Holstein and 99,044 Montbéliarde animals). For DR, the whole French Holstein data base was investigated to find 
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descendants of the founder female Surinam Sheik Rosabel-RED (HOLCAN000003541221). Animals homozy-
gous for the recessive MC1Re red allele were excluded. Genotypes at the MC1R locus are predicted in the rou-
tine genomic evaluation according to haplotype-based information (Capitan et al., unpublished; Supplementary 
Table 12). Finally, phenotypic information could be retrieved from the French breeding companies for 31 DR and 
36 black descendants of Rosabel.
For each defect, 43801 autosomal markers which passed quality control for the current French genomic selec-
tion procedure were considered. Phenotypic segregations in the different pedigrees were analyzed and, for each 
case, only the (maternal or paternal) haplotype assumed to carry the causative mutation was conserved. Similarly, 
for control, only the haplotype assumed to carry the wild type allele was retained. The causative mutation was 
mapped by searching a haplotype shared by all the cases and absent or at a low frequency in the control group. 
Haplotypes were formed by considering a window of 10 consecutive markers (~500 kb) sliding over the whole 
genome.
Screening for positional candidate variants in the DR, GEA and NC mapping intervals. All the 
private heterozygous variants found in affected animals within each of the associated intervals were considered. 
In addition, since for technical reasons structural variants have not been investigated in the complete dataset of 
whole genome sequences, we performed detection of this type of polymorphisms in the DR, GEA and NC map-
ping intervals to ensure that we did not miss any candidate mutation. We analyzed the genomes of one case and 20 
control animals per interval using Pindel7, DELLY8, and visual examination of the whole-genome sequences with 
IGV9 Control animals were selected based on their genotypes for the SNP and small indels previously detected, 
according to the number of rare alleles shared with the case. The aim of this selection was to represent both hap-
lotypes from affected animals within the mapping interval.
Verification of the de novo nature of the heterozygous private variants (all the studies). For 
BD3, the de novo nature of the candidate mutations was confirmed using whole genome sequencing data of the 
parents of the affected animal, and PCR and Sanger sequencing. Details on the animals and PCR primers used are 
presented in Supplementary Tables 1 and 11 respectively. PCR reactions were performed using the Go-Taq Flexi 
(Promega) according to the manufacturer’s instructions on a Mastercycler pro thermocycler (Eppendorf). The 
resulting amplicons were purified and bidirectionally sequenced by Eurofins MWG (Germany) using conven-
tional Sanger sequencing. Polymorphisms were detected with the NovoSNP software62.
For BD1, BD2 and OI, the de novo nature of the candidate mutations was confirmed using PCR and Sanger 
sequencing in a panel of affected and unaffected animals, and DNA samples extracted from the semen (for BD2 
and OI) and/or the blood (for BD1, BD2 and OI) of the mosaic sires.For all other candidate de novo variants, a 
panel of animals including cases and related controls with both DNA and Illumina BovineSNP50 Beadchip hap-
lotype data available in the French Genomic Selection DNA bank and database was genotyped by PCR and Sanger 
sequencing. In a first step, the segregation of the putative de novo alleles and haplotypes of 100 markers (5 Mb) 
surrounding these mutations were studied among the descendants of putative first mutant animals. Haplotypes 
carrying these mutations were identified and, in a second step, ancestors of the putative primo-mutants were 
screened. Identification of carriers of the same identical-by-descent haplotypes but not of the mutant alleles was 
interpreted as a confirmation of the de novo nature of the mutation. For DR, since no ancestor of the first mutant 
heifer was available in our data set, we mined the French Genomic Selection database to identify AI bulls which 
(i) shared the same haplotype as DR animals over the whole DR interval but which (ii) were phenotypically 
black. Among them, JOCKO BESNE (HOLFRAM005694028588), which presented the longest haplotype (inter-
val Chr3:7,928,589–30,728,145) in common with a DR animal (HOLCHEM120093681213), was selected as a 
control carrying the same IBD haplotype but without the DR mutation.
Genotyping of the AED pedigree. Seven affected calves, as well as ten dams and four sires of affected 
calves were genotyped with the Illumina BovineSNP50 Beadchip. Haplotype phases were inferred as described 
above, using a reference set of 8179 Charolais animals. A homozygosity mapping approach63, 64 was applied to 
verify that the seven cases were homozygous for a unique shared IBD segment in their genomes encompassing 
the EDAR frameshift mutation. In addition, the Charolais database was screened for identifying healthy animals 
which (i) were also homozygous for the same 26-Mb IBD segment and (ii) descended from Invincible on only one 
side of their pedigree and from its sire on the other side (Invincible’s sire carries the same haplotype but without 
the EDAR frameshift mutation). DNA from three of these animals, as well as the affected calves and their parents 
were finally genotyped for the frameshift mutation by PCR and Sanger sequencing as previously described.
Mapping of modifier loci for bovine CHARGE syndrome (NC study). Because of the rapid death of 
the most severely affected animals, we were able to obtain DNA samples from only 7 of them. This low number 
is not high enough for mapping but can be used for confirmation. To map modifier loci, we used 89 non-carrier 
animals and 49 mildly affected animals that were still alive at the age of 6 months. All animals were descendants 
of the NC sire and of a homogeneous purebred Montbéliarde dam population. Considering that half of the 1058 
progeny of this bull carried the mutation and that we phenotyped and genotyped most of the progeny still alive at 
the time of the study, these 49 mildly affected animals correspond approximately to the 10% least affected among 
carriers. The mapping method relied on a comparison of haplotype frequencies between both groups (mildly 
affected vs non affected) for sliding windows of 10 consecutive markers over the whole genome. For chromo-
some 14, which contains the CHD7 frameshift mutation, only maternal haplotypes were considered. A Fisher’s 
exact test was used and 10 000 permutations were computed to determine genome-wide and chromosome-wide 
empirical P values.
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Analysis of at risk matings and estimation of the number of AED affected calves per year. The 
expected number of affected animals was determined by analyzing the complete French Charolais pedigree (27 
million animals) using the Pedig software65. In a first step, all descendants of the bull “Invincible” were identified 
and his contribution to their gene pools calculated. Then, calves born from consanguineous matings were identi-
fied and their risk of being homozygous for the EDAR frameshift mutation (which occurred de novo in Invincible) 
was computed as csire * cdam/4 (with csire and cdam being the contribution of Invincible to the gene pool of the sire 
and the dam of the inbred calves). Finally, the number of affected cases per year was estimated by summing the 
risk probabilities for all the inbred calves born during the same period.
Histological analyses (AED, BD3, DR and GEA studies). For optic microscopy analyses, skin biopsy, 
bone section and eye specimens were fixed in 10% neutral buffered formalin for 24 hours and embedded in paraf-
fin wax. Sections (4 µm) were stained with haematoxylin and eosin (HE) or with haematoxylin, eosin and safran 
(HES). Hairs samples from two bulls, one dominant red (MC1RD/D & DRDR/+) and one recessive red (MC1Re/e & 
DR+/+), were placed in a drop of lactophenol on a microscope slide and covered with a cover slip before exami-
nation. The number and shape (with or without tails) of eumelanin patches was evaluated at magnification × 400 
on a total of ten hairs per animal sampled on the flank (n = 5) and on the back (n = 5). Photographs were taken 
with a Nikon camera device.
For immunohistochemical analysis, formalin-fixed, paraffin-embedded skin sections (4 µm) of dominant 
black, (MC1RD/D & DR+/+), recessive red and dominant red animals were mounted on the same slide and 
deparaffinised. Antigen retrieval was done for 1 hour in 10 mM sodium citrate buffer pH6 using a decloaking 
chamber. Nonspecific binding sites were blocked by incubation with 2.5% horse serum (ImmPRESS kit, Vector 
Laboratories). The sections were incubated with 4 µg/mL of primary antibody overnight at 4 °C (polyclonal rabbit 
anti-NFI (H300), reference sc-5567 Santa Cruz Biotechnology). After rinsing with 1 mM PBS (pH 7.5) + 0.05% 
Tween20, the slides were incubated with the secondary antibody (HRP anti-rabbit IgG, ImmPRESS kit, Vector 
Laboratories), for 30 min at room temperature. The signal was revealed using HRP-Green kit (Zytomed systems), 
and the slides were counter stained with hematoxylin.
For electron microscopy analyses, samples were fixed with 2% glutaraldehyde, in 0.1 M sodium cacodylate 
buffer (pH 7.2) for 4 hours at room temperature. Then, they were postfixed with 1% osmium tetroxide containing 
1.5% potassium cyanoferrate, gradually dehydrated in ethanol (30–100%) and embedded in Epon. Semi-thin 
sections (500 µm) and thin sections (70 nm) were cut with a microtome. Thin sections were collected onto 200 
mesh cooper-Paladium grids. Sections were stained with lead citrate. Specimens were examined with a Hitachi 
HT7700 electron microscope operated at 80 kV. Microphotographs were acquired with an AMT charge-coupled 
device camera.
Genomic DNA, total RNA extraction and cDNA preparation from skin biopsies (DR and GEA 
studies). Tissues samples were stored at −80 °C and cryocuts without hair or cartilage were used to extract 
genomic DNA and total RNA from ear skin biopsies. Genomic DNA was purified using the “Genomic DNA 
from tissue Nucleospin kit” (Macherey Nagel), after homogenising 10 mg of cryocuts in lysis buffer. RNA 
extraction was performed with the RNeasy mini kit (Qiagen) for GEA sample series or with the NucleoSpin kit 
(Macherey-Nagel) for the Dominant Red series, and quality control checked on a Bionanalyzer. Only samples 
with a RIN > 6.8 were considered. Considering the one-exon structure of the MC1R gene, a DNAse treatment 
with the DNA-freeTM DNA removal kit (Life Technologies) was performed on the samples from the VR series. 
cDNA samples were prepared using the Superscript III First Strand cDNA Synthesis System (Life Technologies), 
with 100 ng to 1 µg total RNA as starting material, and an equimolar mixture of oligodT and random hexamers 
primers. Finally cDNA concentration was measured using a NanoDrop ND-1000 spectrophotometer (Thermo 
Fischer Scientific).
Analysis of gene expression by qRT-PCR (DR and GEA studies). In a final volume of 20 µL, 5 ng 
of cDNA were mixed with 10 µL of SYBR Green® mastermix (Applied Biosystems) and 300 nM of forward and 
reverse primers. The reaction was programmed on a QuantStudioTM 12 K Flex Real-Time PCR System (Life 
Technologies) as follows: 50 °C for 2 min, 95 °C 5 min, followed by 40 cycles (95 °C for 15 sec and 60 °C for 1 min). 
The primer sequences are indicated in Supplementary Table 11. To ensure a reliable quantification of transcripts 
in bovine skin, the stability of three genes (RPL32, GAPDH and β2-microglobulin) was tested in a set of 11 sam-
ples (from two dominant black, two recessive red and seven dominant red Holstein animals). Their expression 
stability was calculated using the ExpressionSuite software (Life Technologies), and RPL32 was considered as the 
less variable gene (score 0.474) compared to GAPDH (score 0.497) and β2-microglobulin (score 0.643). The target 
transcripts were further quantified using RPL32 as a reference gene. The relative quantification of each transcript 
was calculated with the ΔΔCt method of the ExpressionSuite Software (Life Technologies). Transcript expression 
levels of transcripts in one black Holstein individual were set to a value of 1, and the other expression values were 
calculated relative to this reference.
Quantification of allelic dosage using pyrosequencing (BD2 and GEA studies). Primers were 
designed using PyroMark Assay Design 2.0 software (details in Supplementary Table 11). PCR samples were 
produced using PyroMark PCR Kit (Qiagen). Runs were analyzed by PyroMark Q24 instrument (Qiagen). For 
GEA, we used a range of DNA pools as a scale with the following proportions: 0, 25, 33, 50, 66, 75, 90 and 100% of 
the mutant allele. These pools were obtained by mixing different amounts of purified plasmids containing either 
a wild-type or a R217del fragment of MITF.
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Gene set enrichment analyses on RNA sequencing data (DR study). The RNA sequencing data 
considered in our analyses were obtained from Dorshorst et al.41 and are available at the following: 10.1371/
journal.pone.0128969.s004. Briefly, RNA was extracted from skin samples from three dominant red and three 
dominant black animals. cDNA libraries were generated and sequenced as paired-end 50 base pair reads on an 
Illumina HiSeq. 2000 instrument. Differential expression analyses were performed using DESeq. 2 package. For 
details see Dorshorst et al.41. In this study, a threshold of FDR < 0.05 was used to evaluate significant expression 
changes between dominant red and dominant black skin samples (Supplementary Data 1). Transcript annotation 
was updated using Ensembl release 88 and information from the UCSC Genome Browser (http://genome.ucsc.
edu/; accessed 2017/04/01). We used the “Non-cow RefSeq genes,” “Cow mRNAs from GenBank” and “Cow ESTs 
that have been spliced” tracks to recover the name of protein-coding genes that are predicted to code “unknown 
protein” according to Ensembl. Gene set enrichment analyses were carried out with two software packages using 
different methods and sources of information. To provide a first overview of the over-represented groups of genes, 
we performed two analyses with Enrichr (http://amp.pharm.mssm.edu/Enrichr/)46, 47 using the list of genes that 
are significantly upregulated (FDR < 0.05, fold change >1) and downregulated (FDR < 0.05, fold change <1). We 
focused on Mammalian Phenotype ontology from Mouse Genome Informatics (MGI Mammalian Phenotype 
Level 3 and 4) to gain information on the possible phenotypic consequences associated with modification of gene 
expression in dominant red versus dominant black animals. Then we performed two analyses with Ingenuity 
Pathway Analysis (http://www.ingenuity.com/products/ipa/) using two list of genes (FDR < 0.05 and fold change 
>2 or <0.5, respectively) to identify canonical pathways that are markedly upregulated or downregulated. Results 
of gene set enrichment analyses are presented in Supplementary Tables 8 and 9.
Data availability. WGS data from 1146 out of the 1230 individuals used for filtering are part of the 1000 
Bull Genomes Run 4.0 (Bouwman et al., submitted). The remaining control genomes were deposited in the 
European Nucleotide Archive (ENA) (http://www.ebi.ac.uk/ena) under the accession numbers: PRJEB11962, 
PRJEB11963, PRJEB12092, PRJEB12093, PRJEB12094, PRJEB12095, PRJEB14604, PRJEB5435, PRJEB5965, 
PRJEB7527, PRJEB7528, PRJEB7707, PRJEB8226, and PRJEB18113. The genome sequences of the affected ani-
mals and of Invincible (CHAFRAM001893105503, carrier of a de novo mutation in EDAR) were also depos-
ited in ENA. Sample accession numbers are: SAMEA104055783 for BD1, SAMEA3869562 for the DR bull 
MORSAN AFTERBURN (HOLCANM000009626893), SAMEA3869561 for GEA, SAMEA3869559 for NC, and 
SAMEA3869563 for Invincible in project PRJEB12703; SAMEA3706814 for BD3, SAMEA3706815 for the sire, 
and SAMEA3706816 for the dam in project PRJEB12092; SAMEA3723253 for OI in project PRJEB12324; and 
SAMEA3723308 for BD2 in project PRJEB12325.
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